MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Alert me to new issues of the journal
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism
Mol Pharmacol Sarnataro et al. 70: 1298

Data Supplement

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Alert me to new issues of the journal

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics